These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33330389)

  • 21. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy.
    Wang K; Lu J; Li J; Gao Y; Mao Y; Zhao Q; Wang S
    J Control Release; 2021 Nov; 339():445-472. PubMed ID: 34637819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
    Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
    AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
    Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy.
    Xu C; Chen F; Valdovinos HF; Jiang D; Goel S; Yu B; Sun H; Barnhart TE; Moon JJ; Cai W
    Biomaterials; 2018 May; 165():56-65. PubMed ID: 29501970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment.
    Xie X; Yue T; Gu W; Cheng W; He L; Ren W; Li F; Piao JG
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms.
    Singh RK; Patel KD; Leong KW; Kim HW
    ACS Appl Mater Interfaces; 2017 Mar; 9(12):10309-10337. PubMed ID: 28274115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Skeleton Structure of Mesoporous Silica Nanoadjuvants on Cancer Immunotherapy.
    Tan J; Ding B; Chen H; Meng Q; Li J; Yang C; Zhang W; Li X; Han D; Zheng P; Ma P; Lin J
    Small; 2024 Jan; 20(3):e2305567. PubMed ID: 37702141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-Analysis of Efficacy of Chemotherapy Delivered by Mesoporous Silica Nanoparticles to Tumor-Bearing Mice.
    McGoron A
    Crit Rev Biomed Eng; 2020; 48(6):327-418. PubMed ID: 33641279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global gene expression analysis of cellular death mechanisms induced by mesoporous silica nanoparticle-based drug delivery system.
    Li X; He Q; Shi J
    ACS Nano; 2014 Feb; 8(2):1309-20. PubMed ID: 24392791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations.
    Djayanti K; Maharjan P; Cho KH; Jeong S; Kim MS; Shin MC; Min KA
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
    Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
    Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems.
    Wen J; Yang K; Liu F; Li H; Xu Y; Sun S
    Chem Soc Rev; 2017 Oct; 46(19):6024-6045. PubMed ID: 28848978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy.
    Khaliq NU; Lee J; Kim J; Kim Y; Yu S; Kim J; Kim S; Sung D; Kim H
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine.
    Zhang C; Xie H; Zhang Z; Wen B; Cao H; Bai Y; Che Q; Guo J; Su Z
    Front Pharmacol; 2022; 13():829796. PubMed ID: 35153797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 40. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.